Chinese scientists use supercomputer to cut new drug screening time from years to seconds

Chinese scientists have unveiled a groundbreaking artificial intelligence platform named GalaxyVS, designed to revolutionize drug discovery. Powered by China's latest generation of Tianhe supercomputers, this platform can screen an extensive library of chemical compounds with unprecedented speed. The developers report that the initial drug screening phase, which traditionally takes months or even years, can now be completed in a matter of tens of seconds.

The National Supercomputing Centre in Tianjin, in collaboration with researchers from Tsinghua University's Institute for AI Industry Research, developed GalaxyVS. The platform's daily throughput in predicting molecular interactions is a million times faster than the current world record for supercomputing molecular docking. This significant advancement was announced following the integration of DrugCLIP, an ultra-fast virtual screening method developed by the Tsinghua team and detailed in the journal Science.

GalaxyVS is anticipated to offer a novel approach to identifying lead molecules essential for treating a range of conditions. These include tumors, neurodegenerative disorders, rare diseases, and emerging infectious diseases. The system's speed and efficiency are also expected to be crucial in accelerating drug research during public health emergencies, providing a faster response to potential outbreaks.

The development highlights China's growing prowess in artificial intelligence and supercomputing, particularly in critical fields like healthcare and scientific research. By drastically cutting down the time and resources required for early-stage drug screening, GalaxyVS could pave the way for faster development of new and effective treatments for a multitude of diseases.